Our Investment in GroundGame.Health
We are thrilled to announce that 7wireVentures has led an investment in Summer Health as part of the company’s $10M Series A financing round.
Our Investment in Summer Health
We are thrilled to announce that 7wireVentures has led an investment in Summer Health as part of the company’s $10M Series A financing round.
Tiffany Yu Joins 7wireVentures as Investment Principal
Following a prolific 38-year career at Cigna, Richards brings his extensive health plan and employer expertise to 7wireVentures, helping drive enhanced growth across the firm’s portfolio
Kicking Off Our 7wireVentures MBA Summer Internship for 2024!
We’re excited to officially kick off recruiting for our 7wireVentures 2022 MBA Summer Internship Program!
Announcing the Close of 7wireVentures’ Newest Investment Vehicle: A $217M + Growth & Opportunity Fund
We are pleased to announce that 7wireVentures has raised our latest investment vehicle, a $217M Growth & Opportunity Fund (GO Fund). The new capital will help our team support high-potential companies from our existing portfolio as they advance to later stages of funding, as well as to invest in other compelling Series B and C companies. The closing of our GO Fund brings the Firm’s AUM to over $500M.
Vivante continues to advance digestive care with its $31M Series B fundraising to power its next chapter of growth
Vivante Health, a digital digestive health solution that uniquely addresses the main challenges consumers with Gastrointestinal (GI) conditions face through personalized clinical care, announced a $31M equity financing Series B led by Mercato Partners.
Tom Richards To Join 7wireVentures As Operating Partner
Following a prolific 38-year career at Cigna, Richards brings his extensive health plan and employer expertise to 7wireVentures, helping drive enhanced growth across the firm’s portfolio
Dan Michelson to Join 7wireVentures as Entrepreneur-in-Residence
Former Strata CEO and Top Healthcare Technology Leader to Focus on Helping Portfolio Companies Grow and Scale
NOCD deepens relationship with Cigna through a new $34 million financing round, furthering both organizations’ commitment to ending the global OCD crisis
NOCD announced a $34M financing round co-led by Cigna Ventures and 7wireVentures, with participation from new investor Longitude Capital and existing investors Kaiser Permanente Ventures, F-Prime Capital, Eight Roads Capital, and Health Enterprise Partners.